G35
Conditions
Interventions
Group 1: Patients with an MS diagnosis who participate in the Multiple Sclerosis Register of the DMSG. These patients are interviewed once using a questionnaire on total oestrogen exposure and tested
Sponsors
Klinik für Neurologie, Universitätsklinikum der Ruhr-Universität Bochum
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Written informed consent for participation in the German Multiple Sclerosis Registry. - Definite MS with determinable course or HIS - Primary residence in Germany - Written informed consent for participation in this study
Exclusion criteria
Exclusion criteria: - MS course not determinable - Lack of capacity to consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is the time to reach an EDSS score of 4. This score is collected as part of the patients' clinical routines. | — |
Secondary
| Measure | Time frame |
|---|---|
| A secondary endpoint is the time to reach an EDSS of 3 and 6. These values are collected as part of the patients' clinical routines. Another secondary endpoint is time to transition to SPMS and patient performance in SDMT. | — |
Countries
Germany
Contacts
Public ContactKerstin Hellwig
Klinik für Neurologie, Universitätsklinikum der Ruhr-Universität Bochum, St. Josef-Hospital
Outcome results
None listed